# A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure

> **NCT02998840** · PHASE2 · COMPLETED · sponsor: **AOBiome LLC** · enrollment: 132 (actual)

## Conditions studied

- Prehypertension
- Hypertension, Stage I

## Interventions

- **BIOLOGICAL:** B244
- **BIOLOGICAL:** Vehicle

## Key facts

- **NCT ID:** NCT02998840
- **Lead sponsor:** AOBiome LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-04-25
- **Final completion:** 2017-06-26
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2022-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02998840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02998840, "A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02998840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*